Inventor · disambiguated record
Ulrike Fuhrmann
Also filed as: FUHRMANN ULRIKE
11 granted patents·15 pending applications·161 citations·filing 2000–2014
89Inventor score
Top patents by PatentIndex Score
26 records- 0191US6316432B1Antigestagenically active steroids with a flourinated 17 α-alkyl chainSCHERING AG·Filed 2000·Granted Nov 13, 2001·40 cites·34 claims
- 0288US7388006B2Non-steroidal progestingBAYER SCHERING PHARMA AG·Filed 2003·Granted Jun 17, 2008·51 cites·26 claims
- 0387US6503895B2Antigestagenically active steroids with a fluorinated 17α-alkyl chainSCHERING AG·Filed 2001·Granted Jan 7, 2003·22 cites·25 claims
- 0485US7148213B2Antigestagenically active steroids with a fluorinated 17α-alkyl chainSCHERING AG·Filed 2004·Granted Dec 12, 2006·18 cites·27 claims
- 0585US6806263B2Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chainSCHERING AG·Filed 2002·Granted Oct 19, 2004·17 cites·25 claims
- 0682US8053426B2Progesterone receptor antagonistsBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 8, 2011·12 cites·28 claims
- 0766US9655887B2Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraceptionBayer Pharma AG·Filed 2014·Granted May 23, 2017·1 cites·19 claims
- 0858US2007238714A1Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseasesFUHRMANN ULRIKE·Filed 2007·Application pending·0 cites
- 0955US2005014736A1Composition comprising progesterone-receptor antagonists and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseasesFiled 2004·Application pending·0 cites
- 1054US7378406B2Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseasesSCHERING AG·Filed 2001·Granted May 27, 2008·0 cites·15 claims
- 1153US2004242551A1Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseasesSCHERING AG·Filed 2003·Application pending·0 cites
- 1249US2003013694A1Use and compositions of antiprogestins for treatment of prostate diseasesFiled 2002·Application pending·0 cites
- 1347US2011112057A1Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disordersBAYER SCHERING PHARIMA AKTIENGESELL SCHAFT·Filed 2009·Application pending·0 cites
- 1444US7408060B2Nonsteroidal progesterone receptor modulatorsSCHERING AG·Filed 2006·Granted Aug 5, 2008·0 cites·26 claims
- 1544US2008188448A1Non-steroidal progesterone receptor modulatorsSCHWEDE WOLFGANG·Filed 2007·Application pending·0 cites
- 1644US2009075989A1Non-steroidal progesterone receptor modulatorsSCHWEDE WOLFGANG·Filed 2007·Application pending·0 cites
- 1743US9579330B2Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraceptionBayer Pharma AG·Filed 2013·Granted Feb 28, 2017·0 cites·17 claims
- 1843US2011003778A1Mineralcorticoid receptor antagonists for the treatment of endometriosisBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 1943US2007010514A1Non-steroidal progesterone receptor modulatorsBOTHE ULRICH·Filed 2006·Application pending·0 cites
- 2042US2009099147A1Non-steroidal progesterone receptor modulatorsSCHWEDE WOLFGNAG·Filed 2008·Application pending·0 cites
- 2140US8445469B218-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latterBOHLMANN ROLF·Filed 2005·Granted May 21, 2013·0 cites·20 claims
- 2240US2004072811A1Use of antiprogestins for the induction of apoptosis in a cellFiled 2001·Application pending·0 cites
- 2339US2004121304A1Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligandsFiled 2001·Application pending·0 cites
- 2438US2004157811A1Inhibition of the growth factor dependency of tumor cellsFiled 2001·Application pending·0 cites
- 2538US2006293317A1Use of non-steroidal progesterone receptor modulatorsSCHMEES NORBERT·Filed 2006·Application pending·0 cites
- 2635US2009029953A118-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latterBOHLMANN ROLF·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrike Fuhrmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →